Inventor · disambiguated record
James F. Blake
Also filed as: BLAKE JAMES · BLAKE JAMES F · BLAKE JAMES FRANCIS · BLAKE JR JAMES F
118 granted patents·42 pending applications·967 citations·filing 1999–2025
99Inventor score
Top patents by PatentIndex Score
160 records- 0198US10174028B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·14 cites·29 claims
- 0298US10174027B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jan 8, 2019·17 cites·30 claims
- 0398US10138243B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·14 cites·29 claims
- 0498US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0597US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0697US10689377B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Jun 23, 2020·16 cites·57 claims
- 0797US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0897US10023570B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 17, 2018·14 cites·103 claims
- 0997US8063050B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2007·Granted Nov 22, 2011·63 cites·103 claims
- 1096US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 1196US10208024B22-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinasesARRAY BIOPHARMA INC·Filed 2016·Granted Feb 19, 2019·32 cites·27 claims
- 1296US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 1396US10125134B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·43 cites·9 claims
- 1496US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 1596US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 1695US8003651B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·35 cites·76 claims
- 1794US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 1894US8853199B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Oct 7, 2014·20 cites·33 claims
- 1993US10633381B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·8 cites·7 claims
- 2093US8697715B2Serine/threonine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Apr 15, 2014·21 cites·25 claims
- 2193US8324221B2Pyrimidyl cyclopentanes as Akt protein kinase inhibitorsBANKA ANNA L·Filed 2009·Granted Dec 4, 2012·54 cites·60 claims
- 2293US8178131B2Pyrrolopyridines as kinase inhibitorsLE HUEROU YVAN·Filed 2009·Granted May 15, 2012·24 cites·36 claims
- 2392US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 2492US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 2592US7271178B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Sep 18, 2007·18 cites·17 claims
- 2691US11267812B2KRAS G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·11 cites·34 claims
- 2791US10907215B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2018·Granted Feb 2, 2021·3 cites·27 claims
- 2891US10688100B2Macrocylic compounds as ROS1 kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jun 23, 2020·3 cites·3 claims
- 2991US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 3091US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 3191US7538120B2Method of treating inflammatory diseasesARRAY BIOPHARMA INC·Filed 2005·Granted May 26, 2009·11 cites·9 claims
- 3290US10724102B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2016·Granted Jul 28, 2020·3 cites·44 claims
- 3390US10655186B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted May 19, 2020·3 cites·14 claims
- 3490US9359340B2Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 7, 2016·9 cites·101 claims
- 3590US8981085B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Mar 17, 2015·10 cites·20 claims
- 3690US8372842B2Pyrazolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2009·Granted Feb 12, 2013·15 cites·53 claims
- 3789US11802127B23,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitorsPFIZER·Filed 2022·Granted Oct 31, 2023·1 cites·53 claims
- 3889US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 3989US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 4089US9969727B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted May 15, 2018·6 cites·23 claims
- 4189US8377937B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Granted Feb 19, 2013·15 cites·37 claims
- 4289US7674810B21,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymeraseROCHE PALO ALTO LLC·Filed 2006·Granted Mar 9, 2010·8 cites·15 claims
- 4389US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 4489US6576632B1Biaryl compounds useful as anticancer agentsPFIZER·Filed 2000·Granted Jun 10, 2003·40 cites·6 claims
- 4588US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 4688US8846681B2Pyrimidyl cyclopentanes as AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2011·Granted Sep 30, 2014·11 cites·91 claims
- 4787US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 4887US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 4987US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 5087US9365568B2Pyrrolopyridines as kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jun 14, 2016·4 cites·12 claims
Showing the top 50 of 160 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James F. Blake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →